NYSE: BSX
Boston Scientific Corp Earnings Dates, Reports, Calls

Boston Scientific earnings were $3.5B for the trailing 12 months ending Sep 30, 2026, with 25.9% growth year over year. The latest BSX earnings report on Sep 30, 2026 announced Q3 2026 earnings of $582.0M, down 35.8% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, BSX reported annual earnings of $2.9B, with 56.4% growth.

BSX past earnings growth

How has BSX's earnings growth performed historically?

Company
25.93%
Industry
-7.62%
Market
93.69%
BSX's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
BSX's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
BSX's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

BSX earnings history

Current Revenue
$21.1B
Current Earnings
$3.5B
Current Profit Margin
16.6%
BSX's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

BSX Return on Equity

Current Company
13.9%
Current Industry
14.1%
Current Market
34.5%
BSX's Return on Equity (13.9%)... subscribe to Premium to read more.
High Return on Equity Performance

BSX Return on Assets

Current Company
7.8%
Current Industry
6.7%
BSX is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when BSX announces earnings.

BSX Return on Capital Employed

Current Company
10.23%
Current Industry
13%
BSX has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BSX vs Medical Device Stocks

TickerEBITDAEarningsY/Y EarningsEPS
BSX$5.47B$3.50B+25.32%$2.38
EW$1.66B$1.00B-5.75%$1.74
DXCM$1.56B$991.00M+9.21%$2.59
PHG$3.12B$1.05BN/A-$0.88
STE$1.64B$805.10M+19.56%$8.21

Boston Scientific Earnings Reports & History FAQ

What were Boston Scientific's earnings last quarter?

On BSX's earnings call on Oct 28, 2026, Boston Scientific (NYSE: BSX) reported Q3 2026 earnings per share (EPS) of $0.40, up 21.57% year over year. Total BSX earnings for the quarter were $582.00 million. In the same quarter last year, Boston Scientific's earnings per share (EPS) was $0.51.

If you're new to stock investing, here's how to buy Boston Scientific stock.

Is Boston Scientific profitable or losing money?

As of the last Boston Scientific earnings report, Boston Scientific is currently profitable. Boston Scientific's net profit (also called net income) for the twelve months ending Sep 30, 2026 was $3.50 billion, a 25.43% increase year over year.

What was BSX's earnings growth in the past year?

As of Boston Scientific's earnings date in Oct 28, 2026, Boston Scientific's earnings has grown 25.93% year over year. This is 33.55 percentage points higher than the US Medical Devices industry earnings growth rate of -7.62%. BSX earnings in the past year totalled $3.50 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.